A detailed history of Jacobs Levy Equity Management, Inc transactions in Nevro Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 732,717 shares of NVRO stock, worth $2.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
732,717
Previous 485,738 50.85%
Holding current value
$2.76 Million
Previous $4.09 Million 0.02%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $1.16 Million - $2.49 Million
246,979 Added 50.85%
732,717 $4.09 Million
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $2.21 Million - $3.77 Million
277,383 Added 133.13%
485,738 $4.09 Million
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $11,254 - $17,247
-830 Reduced 0.4%
208,355 $3.01 Million
Q3 2023

Nov 16, 2023

SELL
$18.22 - $25.85 $1.07 Million - $1.51 Million
-58,456 Reduced 21.84%
209,185 $4.02 Million
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $321,973 - $559,680
-14,234 Reduced 5.05%
267,641 $6.8 Million
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $1.61 Million - $2.19 Million
53,335 Added 23.34%
281,875 $10.2 Million
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $4.92 Million - $6.67 Million
134,957 Added 144.21%
228,540 $9.05 Million
Q3 2022

Nov 15, 2022

SELL
$40.66 - $53.03 $115,108 - $150,127
-2,831 Reduced 2.94%
93,583 $4.36 Million
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $55,065 - $104,699
-1,348 Reduced 1.38%
96,414 $4.23 Million
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $2.03 Million - $3.12 Million
-33,878 Reduced 25.74%
97,762 $7.07 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $9.68 Million - $14.5 Million
119,456 Added 980.43%
131,640 $10.7 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $28,149 - $45,915
-276 Reduced 2.22%
12,184 $1.42 Million
Q1 2021

May 17, 2021

BUY
$132.81 - $182.18 $1.65 Million - $2.27 Million
12,460 New
12,460 $1.74 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.